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CIGARETTE SMOKING AND CANCER
Evidence for causal association
Lung (90%)
IARC Vol. 83, 2004
Tobacco Smoke and Involuntary Smoking
Inconclusive evidence for association
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AERODIGESTIVE TRACT TUMORS 50–70% synergism with alcohol
CARDIOVASCULAR DISEASES 30% synergism with other risk factors
COPD 75%
~ 500,000 deaths / yearEU
~ 500,000 deaths / yearUSA
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DNA damage and repair
Cytogenetic effects
Activation of oncogenes
Deletion or mutation of
oncosuppressor genes
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MODULATION OF DNA ADDUCTS BY DIETARY
AGENTS IN THE LUNG OF SMOKE-EXPOSED RATS
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GENOMIC AND TRANSCRIPTIONAL ALTERATIONS





































INTERPLAY BETWEEN HISTOPATHOLOGICAL ALTERATIONS, 
CIGARETTE SMOKE AND CANCER CHEMOPREVENTIVE AGENTS 
IN DEFINING microRNA PROFILES IN MOUSE LUNG
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8 / 202 mo. + 7 mo.
LUNG TUMOR YIELD IN A/J MICE
EXPOSED TO CIGARETTE SMOKE (ECS)
15 / 20** **5 mo. + 4 mo.
P < 0.01**
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INCREASED SUSCEPTIBILITY TO 
CARCINOGENS AT BIRTH: MECHANISMS
Induction of oxidative DNA damage and formation of bulky
DNA adducts 
Overexpression of multiple genes
Increased proliferative rate in neonatal organs
Alterations of xenobiotic metabolism
Lower efficiency of certain DNA repair mechanisms



































INDUCTION OF LUNG TUMORS BY CIGARETTE SMOKE
IN MICE EXPOSED EARLY IN LIFE




































Incidence  = 14/22 (63.6%)
Multiplicity = 6.1 ± 1.64
Incidence  = 12/16 (75.0%)
Multiplicity = 13.6 ± 2.33
Females












































Adenoma Carcinoma in situ
Small cell carcinoma Tumor containing
adenocarcinomatous



















































Swiss H 8 mo. 9/32 (28.1%) 3/32 (9.4%)0-2 mo. 0/36 Unpublished
Swiss H 11 mo. 2/60 (3.3%) 0/603-7 mo. 0/30 Unpublished
Swiss H 7 mo. 15/38 (39.5%) 7/38 (18.4%)0-4 mo. 0/36 Balanskyet al., 2007
Swiss H 7 mo. 24/69 (34.8%) 9/69 (13.0%)0-4 mo. 0/34 Unpublished
Swiss H 7 mo. 16/55 (29.1%) 6/55 (10.9%)0-4 mo. 1/52 Balanskyet al., 2009(1.9%)
Swiss H 8 mo. 16/111(14.4%) 2/111 (10.8%)0-4 mo. 3/64 Unpublished(4.7%)
Swiss ICR 7 mo. 25/82 (30.5%) 0/820-4 mo. 2/57 Unpublished(3.8%)
DBA/2 8 mo. 3/16 (18.8%) 0/160-4 mo. 0/18 Unpublished
C57BL 8 mo. 1/22 (4.5%) 0/220-4 mo. 0/19 Unpublished



































CARCINOGENICITY OF MAINSTREAM 
CIGARETTE SMOKE IN STRAIN H MICE
0 10 20 30 40 50
Incidence of lung tumors (%)
Controls (64 mice)
P < 0.001MCS transpl.(61 mice)
P < 0.001MCS transpl. + neonatal (105 mice)
P < 0.001
Ethanol transpl. + 
MCS neonatal
(72 mice)




























































































CHEMOPREVENTION OF CIGARETTE SMOKE–INDUCED TUMORS









0 10 20 30 40 50 60 70 0 1 2 3 4 5
































































PRENATAL N–ACETYLCYSTEINE (NAC) PREVENTS CIGARETTE
SMOKE–INDUCED LUNG TUMORS IN NEONATAL MICE

























































PRENATAL N–ACETYLCYSTEINE (NAC) PREVENTS CIGARETTE
SMOKE–INDUCED HISTHOPATOLOGICAL ALTERATIONS IN 
NEONATAL MICE
Incidence (%)
















































PRENATAL ASCORBIC ACID (AsA) PREVENTS CIGARETTE
SMOKE–INDUCED LUNG TUMORS IN NEONATAL MICE
Incidence (%) Multiplicity (mean ± SE)















































CHEMOPREVENTION OF CIGARETTE SMOKE–INDUCED
LUNG ADENOMAS BY NATURAL PRODUCTS
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CHEMOPREVENTION OF SMOKE-RELATED 
ALTERATIONS OF microRNAs AND LUNG TUMORS
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